About Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Headquarters
Foundation Medicine, Cambridge
Founded
2010-01-01
Industry
Biotechnology, Genetics, Health Care, Medical
Last Funding Type
Series B
Valuation
0.5
Total Funding
$96.50 million dollars
IPO Status
Public
Financial
Foundation Medicine is advancing personalized cancer therapies through methods for predicting treatment response to mono-immunotherapy and determining tumor mutational burden (TMB) using sequence read data. They are also developing systems for identifying HLA variants and methods for multigene analysis of tumor samples. Their research includes detecting BRAF gene fusions and using tumor heterogeneity scores as prognostic biomarkers. These efforts focus on enhancing diagnostic precision and tailoring cancer treatments.
Funding Rounds
4
Number of Lead Investors
1
Total Funding Amount
$96.50 million dollars
Number of Investors
9